A program to help lung cancer patients manage their symptoms and improve quality of life
Official title: A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
Run by The University of Hong Kong · NCT06377124 · Data updated 2026-11-12
This study tests a mobile program that helps lung cancer patients manage their symptoms and improve their quality of life, while also looking at how it affects their family caregivers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 3 sites (Hong Kong, Ho ManTin and 2 other locations) |
| Status | Recruiting |
| Started | April 22, 2024 |
| Main results expected | March 31, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06377124 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and above with advanced-stage non-small cell lung cancer who are capable of self-care and can communicate in Chinese.
✕Probably not a fit
Patients preparing for lung surgery, those with severe respiratory issues, or uncontrolled pain may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the Smart Self-Management Support Programme (3S), which utilizes mobile devices to assist lung cancer patients in managing their symptoms and improving their quality of life. The program focuses on empowering patients through self-management techniques and aims to enhance their knowledge, skills, and confidence in handling their condition. Participants will be compared to a control group receiving general health information to assess the effectiveness of the 3S intervention. Additionally, the study will examine the impact on family caregivers of the patients involved.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life for lung cancer patients by providing them with effective self-management tools.
How similar studies have gone: Other studies have shown promise in using digital self-management programs for cancer patients, indicating that this approach is both relevant and potentially effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients: Inclusion Criteria: * Aged 18 years or above * Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer * Ambulatory and capable of all self-care activities (ECOG ≤2) * Either undergoing or has finished oncology therapy * Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators * Can speak and read Chinese * Willing to complete the patient-reported outcome questionnaire * Has a smartphone with WhatsApp or WeChat Exclusion Criteria: * Preparing for lung operation * Skeletal fragility * Serious active infection * Inability to walk * Previously untreated symptomatic brain metastases * Severe respiratory insufficiency * Uncontrolled pain * Diagnosed psychiatric illness with or without medication Family Caregivers: Inclusion criteria: * Aged 18 years or above * Family caregivers of recruited patients Exclusion criteria: * Unable to speak and read Chinese * Unwilling to complete the patient-reported outcome questionnaire
Where it's running
-
Queen Elizabeth Hospital
Hong Kong, Ho ManTin, Hong Kong Recruiting -
United Christian Hospital
Hong Kong, Hong Kong Recruiting -
Queen Mary Hospital
Hong Kong, Hong Kong Not yet recruiting
Study contacts
- Principal investigator: Agnes Yuen Kwan Lai, PhD — School of Nursing and Health Sciences
- Study coordinator: Agnes Yuen Kwan Lai, PhD
- Email: ayklai@hkmu.edu.hk
- Phone: 852 3970 2917
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.